Tonix Pharmaceuticals Holding Balance Sheet Health
Financial Health criteria checks 5/6
Tonix Pharmaceuticals Holding has a total shareholder equity of $42.1M and total debt of $8.5M, which brings its debt-to-equity ratio to 20.2%. Its total assets and total liabilities are $70.3M and $28.2M respectively.
Key information
20.2%
Debt to equity ratio
US$8.49m
Debt
| Interest coverage ratio | n/a |
| Cash | US$4.16m |
| Equity | US$42.10m |
| Total liabilities | US$28.20m |
| Total assets | US$70.31m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: TNXP's short term assets ($25.3M) exceed its short term liabilities ($22.0M).
Long Term Liabilities: TNXP's short term assets ($25.3M) exceed its long term liabilities ($6.2M).
Debt to Equity History and Analysis
Debt Level: TNXP's net debt to equity ratio (10.3%) is considered satisfactory.
Reducing Debt: TNXP's debt to equity ratio has increased from 0% to 20.2% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: TNXP has sufficient cash runway for 1 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: TNXP is forecast to have sufficient cash runway for 0 months based on free cash flow estimates, but has since raised additional capital.